PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 16420556

Are B vitamins a risk factor for VTE? Perhaps.

M den Heijer
View original source ↗Export metadata ↓

Abstract

Venous thrombosis is considered as a multicausal disease. Hyperhomocysteinemia is considered as one of the risk factors for venous thrombosis. Because homocysteine levels are strongly influenced by the intake and concentrations of B vitamins, it is worthwhile to assess the role of these vitamins as a risk factor for venous thrombosis.

Explore related subjects

HomocysteineHumansHyperhomocysteinemiaRisk FactorsThromboembolismVenous ThrombosisVitamin B 12Vitamin B 12 DeficiencyVitamin B 6Vitamin B 6 DeficiencyVitamin B DeficiencyJournal ArticleResearch Support, Non-U.S. Gov'tReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M den Heijer. 2006. Are B vitamins a risk factor for VTE? Perhaps.. https://doi.org/10.1111/j.1538-7836.2006.01769.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients.

Hyperhomocysteinemia is a risk factor for cardiovascular disease in the general population, but in end-stage renal disease patients some studies show a reverse association, i.e. higher levels of homocysteine are associated with better clinical outcome. In this brief review, we review the evidence that malnutrition, hypoalbuminemia, inflammation and diabetes mellitus may lower circulating levels of homocysteine. As these factors are strong predictors of clinical outcome, this may explain why lower homocysteine levels in end-stage renal disease patients are associated with worse clinical outcome. We conclude that these factors need to be taken into account in multivariate models evaluating the impact of hyperhomocysteinemia as a risk factor in end-stage renal disease patients.

Homocysteine↗